Consumer Health News and Research RSS Feed - Consumer Health News and Research

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis. [More]

HTMS introduces algorithm-based analytics model, Alfred

HTMS, an Emdeon company, is pleased to introduce Alfred™. Alfred is an algorithm-based analytics model that can help all types of healthcare stakeholders calculate health plan rates and federal subsidies through its comparison and advisory capabilities and is both easy to use and understand. [More]

New research report investigates health benefits of Beta- Carotene and its regulatory status

Reportlinker.com announces that a new market research report is available in its catalogue: Beta-Carotene Industry - Market Trends and Insights [More]
EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients. [More]

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Today the U.S. Food and Drug Administration (FDA) approved over-the-counter Nexium® 24HR (esomeprazole 20mg) marking a key step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years. [More]
Research report on global ophthalmology devices market

Research report on global ophthalmology devices market

The "Ophthalmology Devices Market (Optical Coherence Tomography (OCT) Scanner, Fundus Camera, Tonometer, Pachymeter, Perimeter, Slit Lamp, Excimer, YAG Laser, Femtosecond Laser, IOL, Contact Lens) - Competitive Landscape & Global Forecasts to 2018", published by MarketsandMarkets, the ophthalmology devices market inclusive of diagnostic, monitoring and surgical devices is expected to grow at a CAGR of 6.8% to reach $9,466.7 Million by 2018. [More]
BioRestorative Therapies, Rohto sign Research and Development Agreement

BioRestorative Therapies, Rohto sign Research and Development Agreement

BioRestorative Therapies, Inc., a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement with Rohto Pharmaceutical Company, Ltd. Under the Agreement, BRT has been engaged to provide stem cell research and development services. [More]

Communispace launches new business unit for health care companies

Communispace – the leading consumer collaboration agency – today announced the launch of Communispace Health, a new business unit dedicated to helping health care companies collaborate with consumers to create greater impact and develop competitive advantage in the marketplace. Communispace Vice President, Corey Schwartz, has been named Managing Director of Communispace Health. [More]
Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore, the Life Science division of Merck, today announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan. [More]
Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. [More]
Connecticut Children's OCCH receives $1M grant to address critical public health issues for children

Connecticut Children's OCCH receives $1M grant to address critical public health issues for children

UnitedHealthcare has provided a $1 million grant for the Connecticut Children's Medical Center's Office for Community Child Health to help enhance care delivery and address critical public health issues for children. These issues include child development, wellness, and chronic conditions such as asthma and obesity. [More]
FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start. [More]

Prevently.com: New portal aims to help people live healthier lifestyle

Prevently.com is a new health and wellness portal that aims to help people live a healthier lifestyle. The website provides users with health information reviewed by physicians, virtual video coaching with dietitians, a personal health record that integrates with wearable fitness devices such as FitBit, social networking tools, and an ecommerce portal that allows users to purchase health products and food reviewed by physicians. [More]

UnitedHealthcare, Konami bring DDR CE Classroom Edition "exergame" to Boys & Girls Club of Southern Nevada

UnitedHealthcare and Konami Digital Entertainment, Inc., today are bringing the DanceDanceRevolution (DDR CE) Classroom Edition "exergame" to the Boys & Girls Club of Southern Nevada, where local youths will use the popular dance game to have fun and improve their fitness. [More]

Validic Labs launched to bridge the gap between healthcare companies and mHealth data producers

Validic, pioneer of the first truly inclusive mobile health marketplace, announced today the latest innovation to its data-leveraging platform. Validic has launched Validic Labs in an effort to further bridge the gap between mHealth data producers and healthcare companies. Validic Labs facilitates a simple connection between the app and device developers and the healthcare system in an effort to foster faster, more productive healthcare innovation on both sides. [More]

CVS' tobacco move brings praise, analysis as marketing move

Some are praising CVS' decision not to sell tobacco products while others say it's a marketing ploy meant to position the drugstore keenly in the middle of consumer health care. [More]

Therapath signs contract with United Healthcare to provide neuropathology services

Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare, a division of UnitedHealth Group (NYSE: UNH), to provide the pathology analysis for these specialty services. [More]

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Pfizer Inc. (NYSE: PFE) announced today top-line results from a Phase 3 study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic low back pain. [More]

Takeda expands commercial platform in Israel

Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets. [More]

TELUS Health to offer Medworxx Patient Flow Platform to customers

Medworxx Solutions Inc. today announced that TELUS Health will now offer customers the Medworxx Patient Flow Platform, enabling health care practitioners to better analyze and monitor patient health in an acute care environment. Comprised of Medworxx Clinical Criteria, Bed Management System, and Forms and Assessments, the platform is available as part of TELUS Health's suite of technology solutions. [More]